Recent DXCM News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/15/2026 08:05:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 08:39:16 PM
- Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day • Business Wire • 05/14/2026 08:02:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 01:47:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/11/2026 11:13:02 PM
- Dexcom to Host Investor Day on May 14, 2026 • Business Wire • 05/05/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 09:20:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:02:43 PM
- Dexcom Reports First Quarter 2026 Financial Results • Business Wire • 04/30/2026 08:02:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/29/2026 10:24:53 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (Canada) • 04/29/2026 02:30:00 PM
- Why Medtech Giants Are Quietly Paying Up for AI Diagnostics • PR Newswire (US) • 04/29/2026 02:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 11:27:09 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/15/2026 08:13:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/15/2026 08:11:55 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/15/2026 08:06:56 PM
- Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time • Business Wire • 04/02/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:07:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:02:26 PM
- Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026 • Business Wire • 03/11/2026 06:00:00 AM
